Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Litzman

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Immunology|December 30, 2014
Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patientsJ Litzman
Casopis Lekaru Ceskych|September 11, 1996
[Primary immunodeficiencies. I. Classification and new etiopathogenic findings]J Litzman
Casopis Lekaru Ceskych|September 11, 1996
[Primary immunodeficiencies. II. Current therapeutic possibilities]J Litzman
Casopis Lekaru Ceskych|November 1, 1991
[Current therapeutic use of gamma globulin preparations]J Litzman
Bratislavske Lekarske Listy|November 12, 1998
[Molecular biology basis of combined (T + B) primary immunodeficiency]J Litzman, J Lokaj
Casopis Lekaru Ceskych|December 6, 2003
[Role of aspartic acid at position 57 of the HLA-DQ beta chain in sporadic and familial forms of selective IgA deficiency]T Freiberger, J Litzman, E Vondrusková
Allergologia Et Immunopathologia|May 1, 1995
Analysis of zinc, iron and copper serum levels in patients with common variable immunodeficiencyJ Litzman, M Dastych, P Hegar
Clinical and Experimental Immunology|December 22, 2016
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approachS Jolles, H Chapel, J Litzman
Advances in Experimental Medicine and Biology|January 1, 1995
Incidence of primary immunodeficiencies in a population of south Moravia, CzechoslovakiaJ Lokaj, J Litzman, P Kuklinek
Vnitrni Lekarstvi|May 1, 1996
[Laboratory markers in hepatitis C virus infection in patients with antibody formation disorders treated with immunoglobulin preparations]J Litzman, J Pejcochová, J Lokaj
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|December 30, 2014
Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patientsJ Litzman
Casopis Lekaru Ceskych|September 11, 1996
[Primary immunodeficiencies. I. Classification and new etiopathogenic findings]J Litzman
Casopis Lekaru Ceskych|September 11, 1996
[Primary immunodeficiencies. II. Current therapeutic possibilities]J Litzman
Casopis Lekaru Ceskych|November 1, 1991
[Current therapeutic use of gamma globulin preparations]J Litzman
Bratislavske Lekarske Listy|November 12, 1998
[Molecular biology basis of combined (T + B) primary immunodeficiency]J Litzman, J Lokaj
Casopis Lekaru Ceskych|December 6, 2003
[Role of aspartic acid at position 57 of the HLA-DQ beta chain in sporadic and familial forms of selective IgA deficiency]T Freiberger, J Litzman, E Vondrusková
Allergologia Et Immunopathologia|May 1, 1995
Analysis of zinc, iron and copper serum levels in patients with common variable immunodeficiencyJ Litzman, M Dastych, P Hegar
Clinical and Experimental Immunology|December 22, 2016
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approachS Jolles, H Chapel, J Litzman
Advances in Experimental Medicine and Biology|January 1, 1995
Incidence of primary immunodeficiencies in a population of south Moravia, CzechoslovakiaJ Lokaj, J Litzman, P Kuklinek
Vnitrni Lekarstvi|May 1, 1996
[Laboratory markers in hepatitis C virus infection in patients with antibody formation disorders treated with immunoglobulin preparations]J Litzman, J Pejcochová, J Lokaj
Pageof 6